PHARMACEUTICAL SUBSIDY SCHEME SET FOR ACCELERATION
On April 22, 2025, Government Decree No. 83/2025. (IV. 22.) Amending Government Decree No. 96/2003. (VII. 15.) on the General Conditions for the Practice of Healthcare Services and the Operating Authorization Procedure, and Government Decree No. 452/2017. (XII. 27.) on the Detailed Rules for the Inclusion of Medicines in Social Security Subsidies, Determining the Level of Inclusion and Subsidies, and Amending the Subsidy was published in the Hungarian Official Gazette. According to the rationale of the Government Decree, it aims to reduce administrative burdens and increase the competitiveness of the Hungarian healthcare industry.
Among the various changes, a key development is the amendment of Government Decree No. 452/2017. (XII. 27.) on the Detailed Rules for the Inclusion of Medicines in Social Security Subsidies, the Determination of Inclusion Levels and Subsidies, and the Amendment of Subsidies (hereinafter: the “Decree”).
As a result of these changes, a faster, simplified procedure will be available for applying a price mark-up to medicines listed under the “SH” code in the NNGYK notice, in accordance with the relevant decree on publishing the list of strategic medicines.[1]
Given its greater administrative transparency and efficiency, this simplified procedure will enable domestic pharmaceutical manufacturers to operate more swiftly and effectively.
***
If you have any further questions, please feel free to contact us and request the assistance of KNP LAW experts.
[1] Decree No. 16/2024. (III. 11.) of the Ministry of Interior on the list of medicines of strategic importance
